• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 18
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 

 


Chair

Designated Federal Officer
Yvette Waples, Pharm.D.
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: ACPS-CP@fda.hhs.gov
 

Prabir K. Basu, Ph.D., M.B.A
Expertise: Pharmaceutics
Term: 12/21/2010-10/31/2014
Executive Director
National Institute for Technology and Education
Columbia Center I
5600 N. River Road, Suite 800
Rosemont, Illinois 60018

*Rose Marie Caballero, M.S.N., R.N.
Expertise: Consumer Representative
Term: 12/5/2011 – 10/31/2015
Associate Professor
Del Mar College
Dept. of Nurse Education, Health Science Bldg 3
Room 304
Corpus Christi, Texas 78404

**Jack A. Cook, Ph.D.
Expertise: Clinical Pharmacology
Term: 04/04/2012 – 10/31/2015
Clinical Pharmacology
Specialty Care Business Unit
Pfizer, Inc.
445 Eastern Point Road
MS8260-2504
Groton, Connecticut 06340

**Edwin L. Hemwall, Ph.D.
Expertise: Non-prescription Drug Development
Term: 04/04/2012 – 10/31/2015
Global R&D Franchise Leader
Merck Consumer Care
One Merck Drive
P.O. Box 100
Whitehouse Station, New Jersey 08889-0100

**Peter K. Honig, M.D., M.P.H.
Expertise: Clinical Pharmacology and Drug Development
Term: 04/04/2012 – 10/31/2015
Head, Global Regulatory Affairs
AstraZeneca Pharmaceuticals LP
1800 Concord Pike
P.O. Box 15437
Wilmington, Delaware, 19850-5437

**James J. Keirns, Ph.D.
Expertise: Clinical Pharmacology and Translational Science
Term: 04/04/2012 – 10/31/2015
Vice President
Chief Clinical Pharmacology Scientist
Global Clinical Pharmacology & Exploratory Development
Astellas Pharma Global Development, Inc.
1 Astellas Way, N2.296
Northbrook, IL, 60062

Joseph S. Kosler, Ph.D
Expertise: Statistician
Term: 12/5/2011 – 10/31/2014
U.S. Department of Agriculture
National Agriculture Statistics Service
Research and Development Division
3251 Old Lee Highway, Room 305
Fairfax, Virginia 22031

Fernando J. Muzzio, Ph.D.
Expertise: Pharmaceutical Product and Process Development
Term: 12/09/2009 – 10/31/2013
Professor of Chemical Engineering
Department of Chemical and Biochemistry
Rutgers University
98 Brett Road
Piscataway, New Jersey 08855

Harriet B. Nembhard, Ph.D.
Expertise: Quality and Product Improvement
Term: 11/01/2009 – 10/31/2013
Professor of Industrial Engineering
Pennsylvania State University
310 Leonhard Building
University Park, Pennsylvania 16802

James E. Polli, Ph.D.
Expertise: Biopharmaceutics
Term: 12/09/2009 – 10/31/2013
Professor and Vice-Chair
Department of Pharmaceutical Sciences
University of Maryland School of Pharmacy
20 Penn Street, HSF2 room 623
Baltimore, MD 21201

Fadia T. Shaya, Ph.D., M.P.H.
Expertise: Pharmacoeconomics
Term: 12/21/2010 – 10/31/2014
Professor
University of Maryland School of Pharmacy
Department of Pharmaceutical Health Services Research
220 Arch Street, 12th Floor, Room 01-204
Baltimore, Maryland 21201

Elizabeth M. Topp, Ph.D.
Expertise: Chemical Engineering/Pharmaceutics
Term: 12/5/2011 – 10/31/2015
Head, Dept. of Industrial and Physical Pharmacy
College of Pharmacy, Nursing, and Health Sciences
Purdue University, RHPH
575 Stadium Mall Drive
West Lafayette, Indiana 47907


* Consumer Representative
** Industry Representative (non voting)

-
-